非小细胞肺癌的病理医师间诊断一致性:现行与近期分类的比较
研究通过网页调查让22名病理医师对54例非小细胞肺癌(NSCLC)核心图像进行诊断,比较单独H&E与H&E加黏液及4种免疫组化(IHC)染色、以及2004/2011/2015分类下的病理医师间诊断一致性(IPDA)。结果显示H&E/黏液/IHC诊断的IPDA显著高于单独H&E,且2015分类下最高;合并亚类或二分类后IPDA估计更高;IPDA在社区与学术病理医师间相似,但在有肺部病理专长、执业超过6年或每年诊断超过100例新肺癌病例的医师中更高。
要点
- 加做黏液和4种IHC染色可显著提高NSCLC的病理医师间诊断一致性。
- 2015年WHO分类下H&E/黏液/IHC诊断的IPDA最高。
- 肺部病理专长、执业超过6年、年诊断肺癌超过100例与更高IPDA相关。
核心结论
- 使用黏液和IHC染色、采用2015年NSCLC分类以及病理医师具备肺部病理专长、较长执业年限和较多肺癌病例诊断经验与更高的IPDA相关。
研究设计与样本
- 基于网页的调查,22名执业病理医师对54例NSCLC病例的核心图像进行诊断,初始仅H&E,随后加黏液和4种IHC染色,分别按2004、2011和2015年发布的NSCLC分类诊断,计算231对病理医师的Cohen's kappa作为IPDA度量。
主要发现
- H&E/黏液/IHC诊断的IPDA显著高于仅H&E诊断。
- H&E/黏液/IHC诊断的IPDA在2015分类下最高。
- 将诊断合并为亚类或二分类后IPDA估计更高。
- 2015年WHO分类下H&E/黏液/IHC诊断的IPDA在社区和学术病理医师间相似。
- 当病理医师具有肺部病理专长、执业超过6年或每年诊断超过100例新肺癌病例时IPDA更高。
关键数值与推荐
- H&E/黏液/IHC诊断的IPDA显著高于仅H&E诊断(具体数值未在摘要中报告)。
- H&E/黏液/IHC诊断的IPDA在2015分类下最高(具体数值未在摘要中报告)。
- 合并诊断至亚类或二分类后IPDA估计更高(具体数值未在摘要中报告)。
- 2015年WHO分类下H&E/黏液/IHC诊断的IPDA在社区和学术病理医师间相似(具体数值未在摘要中报告)。
- 具有肺部病理专长、执业超过6年或每年诊断超过100例新肺癌病例的病理医师IPDA更高(具体数值未在摘要中报告)。
临床怎么用
- 在NSCLC诊断中应常规结合黏液染色和IHC染色以提高诊断一致性。
- 采用2015年WHO分类有助于提高病理医师间诊断一致性。
- 病理医师的肺部病理专长、执业经验和肺癌病例诊断量可影响诊断一致性。
局限性
- 研究基于网页调查和核心图像,非真实临床切片。
- 样本量有限(22名病理医师,54例病例)。
- 摘要未报告具体IPDA数值和统计细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT.—: Measurement of interpathologist diagnostic agreement (IPDA) should allow pathologists to improve current diagnostic criteria and disease classifications. OBJECTIVES.—: To determine how IPDA for pathologists' diagnoses of non-small cell lung carcinoma (NSCLC) is affected by the addition of a set of mucin and immunohistochemical (IHC) stains to hematoxylin-eosin (H&E) alone, by recent NSCLC reclassifications, by simplification of these classifications, and by pathologists' practice location, pulmonary pathology expertise, practice duration, and lung carcinoma case exposure. DESIGN.—: We used a Web-based survey to present core images of 54 NSCLC cases to 22 practicing pathologists for diagnosis, initially as H&E only, then as H&E plus mucin and 4 IHC stains. Each case was diagnosed according to published 2004, 2011, and 2015 NSCLC classifications. Cohen's kappa was calculated for the 231 pathologist pairs as a measure of IPDA. RESULTS.—: Twenty-two pathologists diagnosed 54 NSCLC cases by using 4 published classifications. IPDA is significantly higher for H&E/mucin/IHC diagnoses than for H&E-only diagnoses. IPDA for H&E/mucin/IHC diagnoses is highest with the 2015 classification. IPDA is estimated higher after collapse of stated diagnoses into subhead or dichotomized classes. IPDA for H&E/mucin/IHC diagnoses with the 2015 World Health Organization classification is similar for community and academic pathologists, and is higher when pathologists have pulmonary pathology expertise, have more than 6 years of practice experience, or diagnose more than 100 new lung carcinoma cases per year. CONCLUSIONS.—: Higher IPDA is associated with use of mucin and IHC stains, with the 2015 NSCLC classification, and with pathologists' pulmonary pathology expertise, practice duration, and frequency of lung carcinoma cases.
引用
- Funkhouser WK, Hayes DN, Moore DT, et al. Interpathologist Diagnostic Agreement for Non-Small Cell Lung Carcinomas Using Current and Recent Classifications. Arch Pathol Lab Med. 2018. PMID: 29708428. doi:10.5858/arpa.2017-0481-OA
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。